Clinical Trial Update: Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream [Phase 2]

View source ↗

Summary

Phase IIb, 12-week trial of non-steroidal topical WBI-1001 Cream for atopic dermatitis has completed (NCT01098734).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• WBI-1001 Cream (WBI-1001)

Snippet

Sponsor: Welichem Biotech Inc. | Conditions: Dermatitis, Atopic | Phase 2 | Status: COMPLETED